OIL 0.00% 20.0¢ optiscan imaging limited

Ann: Response to ASX Query, page-8

  1. 231 Posts.
    lightbulb Created with Sketch. 18
    Farcical.  Comical. But as a shareholder also painful.

    Morrison6.   No news means no good news.  gmutton's post from 16/5/15 is the latest best info (thanks again gmutton):

    ... the following is a history of some of the clinical trials that have already taken place. There will be a confirmatory trial after the consultative process for FDA approval of the system incorporating the sheath. That approval is the one that Optiscan and consultants are working on atm and scheduled for later this year. We should get more on this from the promised June Qtr update. The process design needs to be ticked off by the FDA otherwise any trial on the way to approval runs the risk of not being recognised. I think we have wasted enough time not to take any risk of that happening!!

    "The initial critical path item is the engagement of our regulatory consultant, which will lead to direct liaison with the FDA and will refine the final steps to completion of the neurosurgery
    system development. This engagement has commenced and, among other things, will address
    two critical issues:
    • Exact study requirements around the integration of the disposable sheath into the larger
    neurosurgery live imaging system; and
    • The scope and timing of design transfer into production.
    The outcome of the regulatory consultant process will clarify both the timing and cost of these
    remaining steps of the neurosurgery system development. As commented above, we expect this product development to be complete in the December half this year and we will report the
    outcomes of the consultation process in the June quarter."


    From the Chairmans address at the 2013 AGM talking about the sheath.

    "I am however pleased with the point we have now reached with this final component which is now only subject to small manufacturing advancement and sterility and packaging related testing. The result is an elegant, high quality disposable sterility solution for our rigid neurosurgery endomicroscopy systems. Once this final testing is complete, a further small human trial will be conducted after which regulatory submission will be made."

    Some of the trials already taken place from 2009
    https://clinicaltrials.gov/ct2/show/record/NCT00949793?term=zeiss endomicroscopy&rank=1

    http://www.ncbi.nlm.nih.gov/pubmed/20087141

    http://www.ncbi.nlm.nih.gov/pubmed/21336204

    http://www.ncbi.nlm.nih.gov/pubmed/22283191
 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $167.0M
Open High Low Value Volume
20.0¢ 21.0¢ 19.3¢ $48.20K 237.2K

Buyers (Bids)

No. Vol. Price($)
1 1031 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 3884 1
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.